However, we characterized further the tumor-infiltrated NK cells, and we observed an increase of cytotoxic mature NK cells, as shown by the degranulation marker CD107a and NK cell activation markers (CD69+ and NKG2D+/NKp46+) in mice treated with AU-15330 and cisplatin (Fig. 7F). The gene discussed is KLRK1; the disease is neoplasm.